HerpeVac Trial for Young Women

PHASE3CompletedINTERVENTIONAL
Enrollment

8,323

Participants

Timeline

Start Date

January 14, 2003

Primary Completion Date

August 22, 2009

Study Completion Date

August 22, 2009

Conditions
Herpes Simplex Infection
Interventions
BIOLOGICAL

HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine

the vaccine was administered intramuscularly in the non-dominant deltoid

BIOLOGICAL

Havrix™, GlaxoSmithKline (GSK) Biologicals' licensed Hepatitis A vaccine

the vaccine was administered intramuscularly in the non-dominant deltoid

Trial Locations (75)

10029

GSK Investigational Site, New York

10461

GSK Investigational Site, The Bronx

11201

GSK Investigational Site, Brooklyn

11203

GSK Investigational Site, Brooklyn

14620

GSK Investigational Site, Rochester

14642

GSK Investigational Site, Rochester

15063

GSK Investigational Site, Monongahela

15090

GSK Investigational Site, Wexford

15241

GSK Investigational Site, Pittsburgh

15904

GSK Investigational Site, Johnstown

16125

GSK Investigational Site, Greenville

16127

GSK Investigational Site, Grove City

20742

GSK Investigational Site, College Park

21201

GSK Investigational Site, Baltimore

21224

GSK Investigational Site, Baltimore

27599

GSK Investigational Site, Chapel Hill

27607

GSK Investigational Site, Raleigh

30322

GSK Investigational Site, Atlanta

30460

GSK Investigational Site, Satesboro

30602

GSK Investigational Site, Athens

35294

GSK Investigational Site, Birmingham

37232

GSK Investigational Site, Nashville

40004

GSK Investigational Site, Bardstown

40202

GSK Investigational Site, Louisville

40536

GSK Investigational Site, Lexington

45229

GSK Investigational Site, Cincinnati

46202

GSK Investigational Site, Indianapolis

47405

GSK Investigational Site, Bloomington

52242

GSK Investigational Site, Iowa City

54601

GSK Investigational Site, La Crosse

63104

GSK Investigational Site, St Louis

67005

GSK Investigational Site, Arkansas City

67114

GSK Investigational Site, Newton

67205

GSK Investigational Site, Wichita

67207

GSK Investigational Site, Wichita

68134

GSK Investigational Site, Omaha

70112

GSK Investigational Site, New Orleans

70808

GSK Investigational Site, Baton Rouge

74105

GSK Investigational Site, Tulsa

77030

GSK Investigational Site, Houston

77598

GSK Investigational Site, Webster

78705

GSK Investigational Site, Austin

80045

GSK Investigational Site, Aurora

84119

GSK Investigational Site, Salt Lake City

85014

GSK Investigational Site, Phoenix

85032

GSK Investigational Site, Phoenix

85203

GSK Investigational Site, Mesa

85213

GSK Investigational Site, Mesa

85224

GSK Investigational Site, Chandler

85283

GSK Investigational Site, Tempe

90048

GSK Investigational Site, Los Angeles

90502

GSK Investigational Site, Torrance

90747

GSK Investigational Site, Carson

90840

GSK Investigational Site, Long Beach

92108

GSK Investigational Site, San Diego

92182

GSK Investigational Site, San Diego

94115

GSK Investigational Site, San Francisco

94589

GSK Investigational Site, Vallejo

97210

GSK Investigational Site, Portland

98104

GSK Investigational Site, Seattle

30912-3500

GSK Investigational Site, Augusta

60612-7323

GSK Investigational Site, Chicago

02118

GSK Investigational Site, Boston

87131-0001

GSK Investigational Site, Albuquerque

11794-8091

GSK Investigational Site, Stony Brook

02881

GSK Investigational Site, Kingston

84132-2405

GSK Investigational Site, Salt Lake City

T6G 2B7

GSK Investigational Site, Edmonton

V3R 8P8

GSK Investigational Site, Surrey

R3E 0J9

GSK Investigational Site, Winnipeg

B3K 6R8

GSK Investigational Site, Halifax

B2N 1L2

GSK Investigational Site, Truro

M4S 1Y2

GSK Investigational Site, Toronto

G1E 7G9

GSK Investigational Site, Beauport

J1H 1Z1

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY